We use cookies on this site to improve your browsing experience, as further explained in our
Privacy Policy
. Please click OK to signify your consent to our use of cookies. You can reject cookies by changing your browser settings.
OK
Search for:
I am ...
Je suis ...
Newly diagnosed
Looking for info on Crohn's or colitis
A donor
A volunteer
A researcher
A nurse
Donate Now
Home
About Crohn’s & colitis
What are Crohn’s and colitis?
Signs and Symptoms
Are you at risk?
IBD Journey
COVID-19 and IBD
Webinars and updates
Task Force
2021 Impact of COVID-19 and IBD in Canada Report
FAQs
Support for You
MyGut™
GoHere® Washroom Access
Service Finder
Gutsy Learning Series and Webinars
Past Event Videos
Support and Services
Expert Q&A
Meet the Experts
Information and Resource Hub
Brochures and Booklets
IBD Kitchen
IBD Scholarship
Application Information
Scholarship Application Form
Clinton Shard Memorial Scholarship
Scholarship FAQ
Recipients
Youth Wellness Series
Camp Got2Go
Alberta Camp
Nova Scotia Camp
Ontario Camp
Application
Camp FAQs
Camp Videos
Resources for Healthcare Providers
Inflammatory Bowel Disease Clinical Care Pathways
Living with Crohn’s & Colitis
Newly Diagnosed
Treatments and Medications
Medications
Emerging Treatments
Nutritional Therapies
Surgery
Clinical Guidelines for Ulcerative Colitis
Diet and Nutrition
Probiotics and Prebiotics
Coping Emotionally
Relationships and Intimacy
Fertility and Pregnancy
Living with an Ostomy
Complications
Government Financial Support
Insurance and IBD
Travel
If Your Child has Crohn’s or Colitis
Research
Your Donations Drive Our Research
Research Impact
Research News
Funded Research
Finding Causes and Triggers
Discovering Novel Treatments
Helping Manage Symptoms
Getting the Best Care
The GEM Project
PACE Network
Apply for Funding
Research Partnerships
Participate in Research
Canadian IBD Nursing
About CANIBD
Fellowships and Grants
Learning for Nurses
Get Involved with CANIBD
IBD Researchers and Healthcare Providers
Events and Conferences
Scientific and Medical Advisory Council
Ways to Give
Gutsy Walk™
Donate Now
Buy an eCard
Create a Fundraiser
Fundraising Page Tutorial
Become a Monthly Donor
In Honour Donation
Legacy Giving
Wills & Charitable Bequests
Gift of Stocks & Securities
Gift of Life Insurance
Gift of RRSPs & RRIFs
Gift of Property, Trust & Annuities
Endowments/Chairs/Professorships
Resources
Confidential Notification of Bequest to Crohn’s and Colitis Canada
Join a Local Event
Employer Matching Gifts
Become a Sponsor
Additional Ways to Give
Get Involved
Gutsy Walk™
Volunteer With Us
Current Volunteer Postings
Submit Your Application
Volunteer Impact
Volunteer Tools
Volunteer Learning and Development Program
Presenters
Agenda and Registration
FAQ
Advocating for change
Non-Medical Switch: Biosimilars
Patient Perspective
Building Awareness
Help Build Awareness
November is Crohn’s & Colitis Awareness Month
About Us
Our Leadership
Board of Directors
Strategic Leadership Team
Who We Are
Promise and Values
Strategic Plan
Our Impact
Annual & Financial Reports
Previous Annual Reports
Previous Financial Statements
Celebrating Our Supporters
Careers
Resources & Publications
Talk About Guts e-Newsletter
Research Report
Impact of IBD in Canada Report
Policies
Privacy Policy
Whistleblower Policy
Resolving Community Member’s Concerns
Guidelines for Business Conduct
Respect in the Workplace
Canadian Consensus Framework for Ethical Collaboration
Accessibility Policy
Awards
Physician of the Year Award
IBD Nurse of the Year Award
Finkelstein Award
Lifetime Achievement Award
Volunteer Achievement Awards
Research Awards
Pacesetter Award
50th Anniversary
Our Stories
Research Milestones and Impact
Our Photos
We Need to Act Today
News & Events
News
Events
Media Contacts
Contact
Find My Community
E-News Signup
Training
Risk infographic-coded
IBD Patient Risk
Listed below are the details pertaining to the three sections.
IBD PROFILE
Under 65 years old
and
NOT TAKING
immunosuppressive and biologic medications,
and
IBD in remission, no significantly active inflammation
Not malnourished
No comorbidities (respiratory, cardiac, hypertension, diabetes)
RECOMMENDATION
Follow
public health guidelines
for general population (physical distancing
1
, hand hygiene, self-monitoring, etc.)
IBD PROFILE
Age 65 years or older and using immunosuppressive medications
2
:
Age less than 65 years old, and
TAKING
immunosuppressive medications
2
:
Immunomodulators: azathioprine (Imuran), 6-mercaptopurine (Purinethol), methotrexate
Anti-TNF biologics: infliximab (Remicade
®
, Inflectra
®
, RenflexisTM), adalimumab (Humira
®
), golimumab (Simponi
®
)
Anti-IL12/23 biologics: ustekinumab (Stelara
®
)
Anti-leukocyte migration biologics: vedolizumab (Entyvio
®
)
AJAK inhibitor small molecules: tofacitinib (Xeljanz
®
)
RECOMMENDATION
In addition to following
public health guidelines
for general population (physical distancing
1
, hand hygiene, self-monitoring, etc.):
Avoid in-person meetings
If possible, work at home and hold meetings with virtual technology
If not possible, talk to your physician, and discuss options with your employer for modified duties
3
Use services for vulnerable people (grocery store times for vulnerable populations, laboratory or health care services for vulnerable populations, etc.) in order to avoid contact with other people
IBD PROFILE
65 years or older,
or
under 65 years AND
Oral or intravenous systemic corticosteroids more than 20 mg/day (or 0.5 mg/kg for children) prednisone equivalents:
Prednisone (Deltasone)
Methylprednisolone
Hydrocortisone (Hydrocort, Cortate)
Moderate or severely active inflammation (new diagnosis or recent flare)
Moderate or severe malnutrition
Requirement of parenteral nutrition (intravenous nutrition through a central line)
RECOMMENDATION
In addition to following
public health guidelines
for general population (physical distancing
1
, hand hygiene, self-monitoring, etc.):
SELF ISOLATE
4
Refer to considerations for other family members and people who live with high risk individuals
5
NOTES:
PHYSICAL DISTANCING means:
Keep a distance of 2 metres from the nearest person
If possible, cancel group events and hold meetings virtually rather than in-person
Avoid people who are sick
Do not shake hands, hug, or engage in physical contact with other people, especially if they are sick
Practice good hand hygiene
. Wash your hands with soap and water regularly after social contact, before meals, and often in between, or use hand sanitizer that contains at least 60% alcohol when soap and water is not available. Avoid touching your face. Cough into your sleeve.
Please note that not everyone is at the same risk of serious COVID-19 disease. For example, children and adolescents are more likely to have mild symptoms of COVID-19. We don’t know whether children and adolescents on immunosuppressive medications have a higher risk of COVID-19 complications. Therefore, we have considered everyone on immunosuppressive medications to be vulnerable for serious COVID-19 disease.
People working in essential services in the Medium Risk group (such as health care providers) should consider balance the public need for these essential services with the higher risk of contracting COVID-19. Further guidance can be provided by your local public health authority.
Self-isolation means:
stay at home and monitor yourself for symptoms, even if mild, for 14 days
avoid contact with others
If you have no symptoms of COVID-19, you can still go outside for:
fresh air
a run
a bike ride
to walk the dog
Considerations for other family members and people who live with high risk individuals. In general:
avoid being in close proximity with other people, who might give your family member COVID-19, resulting in transmission to you
Try to avoid in-person meetings
Try to work from home. If not possible, speak to your employer about physical distancing at work
Use services for vulnerable people (e.g. special grocery store times, pharmacy delivery, etc.)
Clean your residence as best as possible to avoid transmission of the virus. Instructions for disinfecting your residence are available from the
Centers for Disease Control and Prevention
While doing these activities, always maintain a distance of at least 2 arms-length (approximately 2 metres) from others.
Refer to our guidance for more information on
how to self-isolate at home when you may have been exposed and have no symptoms
.
Quick Fact
Faits en bref
Canada
has among the highest incidence rates of Crohn's and colitis in the world.
1 in 140
Canadians lives with Crohn’s or colitis.
Families
new to Canada are developing these diseases for the first time.
Incidence of Crohn’s in Canadian kids under 10 has doubled
since 1995.
People are most commonly diagnosed before
age 30.
Michael Thompson Memorial Golf Tournament
Smash The Guts Pickleball Mixer
Top
Haut